Leica Biosystems has added Tempus’ Paige PanCancer Detect and Paige Prostate AI tools to the Aperio AI Store, expanding integrated digital pathology solutions for oncology research within the Aperio HALO AP platform.
CMS has released preliminary 2027 CLFS rates, with data showing weighted median payment cuts for over 1,100 test codes; annual reductions are capped at 15% from 2027 to 2029 under current policy.
Tampa General Hospital is the first in the Southeast to implement the MeMed BV host-response test in its emergency workflow, reporting a 33% reduction in cefepime use and 13% fewer hospitalizations, according to hospital-led research.
The Association for Diagnostics & Laboratory Medicine recommends that AI tools in clinical labs remain under existing CLIA oversight, citing the need for established validation and monitoring standards in response to a federal RFI.
The University of Reading has developed the TRIPLEcheck assay to personalize antiplatelet therapy by assessing platelet reactivity, with a 400-patient clinical trial underway.
